The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
about
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsInhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infantsInhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesEarly administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsLate (>7 days) postnatal corticosteroids for chronic lung disease in preterm infantsInhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infantsEarly administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesInhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesDelayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infantsModerately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsHuman SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasoneRefractory hypotension in preterm infants with adrenocortical insufficiencyEarly administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.Prediction of chronic neonatal lung disease in very low birthweight neonates using clinical and radiological variablesSurfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease.The fetal and neonatal hypothalamic-pituitary-adrenal axis.Inhaled glucocorticoid therapy in infants at risk for neonatal chronic lung disease.Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease.Antenatal corticosteroids alter insulin signaling pathways in fetal baboon skeletal muscleCardiac effects of short course dexamethasone in preterm infantsSystematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease.Cerebral haemodynamics in preterm infants after exposure to dexamethasoneChanges in markers of bone metabolism during dexamethasone treatment for chronic lung disease in preterm infants.Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn.Inhibition of pulmonary β-carotene 15, 15'-oxygenase expression by glucocorticoid involves PPARα.The role of corticosteroids in respiratory diseases of children.The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndromeA randomized trial of inhaled versus intravenous steroids in ventilator-dependent preterm infants.Short-term growth of premature infants treated with dexamethasone assessed by mini-knemometry.Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
P2860
Q24194676-C5FBE0B3-8BC3-454B-8C42-7B3A37709A93Q24194710-C3C56A40-2E89-4E48-8325-39D0CDBC30F6Q24197845-1181A1B4-61FA-4975-8DCA-28004D0FB831Q24197850-46BA5457-A869-423A-8AB8-A08F3074217EQ24197860-329FCB18-D99D-4CEF-8F9F-EAB56DA3FA33Q24240398-5C85AFD1-148B-476E-9F37-FBA1B9B461DAQ24241502-1DC3850B-B29D-4DE9-A516-BE5AEDB2AAC4Q24243584-A968C87F-C590-4A67-B3C3-990F23ABB529Q24243622-6E397A4D-927E-4FC6-8BB6-9B9B355BB91FQ24250182-24D7132F-90BB-465D-94C5-B187F29DFA76Q24250246-C39F262A-00C0-4CD3-9F7A-9EABB677FE0DQ24250284-BE7DC581-EACA-498F-8C23-2CC029B909FFQ28188786-AB6BF7DF-6B39-44BD-B1EC-947B0A8AC15CQ28350961-8C959274-97E2-4BDF-BB39-537DC14F5D88Q30239811-61F9E148-7E67-46EB-96AE-871EF054F23DQ33706474-48DB1F18-1E73-41BB-A323-7A29C545FD65Q33706562-DED50DD8-7B66-4A13-85A9-D6680470397FQ33905618-B66EC9E0-2DE2-4AC8-A087-AFF7CF428A9AQ34074045-75D10CD9-8F5C-4CE9-9113-4734C6976547Q34074665-6F4530DA-AC5B-44C0-BB4A-51820204E1C8Q35141925-432988F6-8826-4DE6-8551-393AE411EA34Q35286526-FC3091C7-1815-4042-B21F-F6860D01F4F9Q35287062-FBE7626A-F3D7-49A1-A267-8FA1A573140FQ35287363-0D3533FB-B028-4D10-B17B-84EE42DE70D0Q35291513-76CB8662-BBFF-441C-9937-F9EC0A5788E6Q35294711-6C4E45CD-A96A-4966-9776-E6A7FA657D6AQ41090165-BDA14714-7FAD-4F21-AF0D-5B8EB3129731Q41151318-008E6B4F-0DB6-409B-9329-B712F657C117Q41811552-063E9F3F-45C5-4AC3-90E3-3F53418C7FF9Q42096475-47469624-86FE-44FB-95F8-1BE0A6634E9AQ43955933-4FF7B3F5-36E0-4B8A-B885-16202ABF0FF2Q45129682-8C04F7C2-EDB1-455E-82F2-814DCF7E1870Q47181565-1E6F0E7F-950D-4A9E-B260-F339396EA038Q47182016-D9049BF1-155A-4FB4-8051-3459278DF75BQ47235829-92B91C99-F900-4AD2-BA10-62B377F6EB41Q47235844-E4B71788-F1F2-4C6A-88A5-1C5EF828FA64
P2860
The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The effectiveness and side eff ...... th bronchopulmonary dysplasia.
@en
type
label
The effectiveness and side eff ...... th bronchopulmonary dysplasia.
@en
prefLabel
The effectiveness and side eff ...... th bronchopulmonary dysplasia.
@en
P2860
P921
P1476
The effectiveness and side eff ...... th bronchopulmonary dysplasia.
@en
P2093
P2860
P304
P356
10.1136/ADC.68.3_SPEC_NO.330
P407
P433
P577
1993-03-01T00:00:00Z